Micro Aftermath Archived

Summit Therapeutics clinical trial updates

Activity declining — narrative losing relevance.

Score 0.3

Velocity ▲ 0.0

Articles 6

Sources 1

Sentiment Timeline

Event Timeline

Jun 30, 2026 Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy … Neutral

Jun 22, 2026 Summit Therapeutics (SMMT): A $500 Million Stock Offering Pulled Just One Day … Neutral

Jun 14, 2026 Summit Therapeutics (SMMT) Raises $500 Million Through Public Offering Bullish

Jun 05, 2026 Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in … Bullish

Jun 02, 2026 Cantor Fitzgerald Maintains Overweight Rating on Summit Therapeutics (SMMT) Amid Mixed Clinical … Neutral

Summit (SMMT) Reports Positive Phase III Overall Survival Data for Ivonescimab in Advanced NSCLC Yahoo Finance · Jun 05, 2026 Bearish

🤖 AI Overview

What happened: On May 31, Summit Therapeutics (SMMT) announced positive Phase III overall survival data from the HARMONi-6 trial, evaluating ivonescimab plus chemotherapy versus tislelizumab in advanced non-small cell lung cancer (NSCLC). The company also presented Phase II data for AK112-206 in the same week. Cantor Fitzgerald maintained an 'Overweight' rating on SMMT despite mixed clinical developments.

Market impact: The positive HARMONi-6 results drove a 30% increase in SMMT's stock price, benefiting investors with high short interest. The biotechnology sector, particularly companies focused on lung cancer treatments, may see increased interest. However, the mixed results from other trials could limit broader market impact.

What to watch next: Key upcoming catalysts include the release of detailed HARMONi-6 data at an upcoming medical conference, expected in Q3 2023. Additionally, the HARMONi-3 trial's results, evaluating ivonescimab in first-line NSCLC, are anticipated in Q4 2023. These events will significantly influence SMMT's stock performance and the market's perception of its pipeline.

AI Overview as of Jun 05, 2026

Timeline

Last UpdatedJun 02, 2026

Summit Therapeutics clinical trial updates

Sentiment Timeline

Event Timeline

Related Articles